Metacare
A Science Centric Care for Better Cardio-Diabetic Health
At Metacare, we go beyond treatment. We create comprehensive therapy solutions that empower individuals to take charge of their health and well-being. As a cardio-diabetic division of Iberia Pharmaceuticals, we are committed to delivering science-backed, patient-centric solutions that address the growing challenges of diabetes, cardiovascular diseases, and metabolic disorders.
With a trusted portfolio of formulations, we lead the way in diabetes management, offering time-tested therapies that combine in-depth research with clinical efficacy. Our range includes Glimepiride, Metformin, Pioglitazone, and Sitagliptin, ensuring targeted action for uncontrolled high-risk Type 2 Diabetes Mellitus (T2DM).
Beyond diabetes, Metacare provides specialized solutions for hypertension, high cardiovascular risk, and lipid disorders. Our formulations are designed to reduce the risk of cardiovascular events, support cholesterol management, and improve overall patient outcomes.
Why Choose Metacare?
We believe in delivering more than just medication—we deliver confidence, care, and a commitment to healthier lives.
Clinically Proven Therapies
Backed by research, trusted by experts.
Comprehensive Cardio-Diabetic Solutions
Targeted treatments for better health.
Patient-Centric Approach
Prioritizing safety, efficacy, and well-being.